Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Dexchlorpheniramine is a first-generation antihistamine used to treat symptoms of allergic reactions, including hay fever, hives, and allergic conjunctivitis. It works by blocking H1 receptors to reduce the effects of histamine in the body.
Name
Dexchlorpheniramine
Raw Name
DEXCHLORPHENIRAMINE MALEATE
Category
Other
Salt Form
Maleate
Drug Count
6
Variant Count
6
Last Verified
February 17, 2026
RxCUI
1369424, 1990881, 2671454, 2183907, 2183912, 2184108
UNII
69QQ58998Y, B10YD955QW, 6V9V2RYJ8N, 9D2RTI9KYH, 04JA59TNSJ
About Dexchlorpheniramine
Dexchlorpheniramine is a first-generation antihistamine used to treat symptoms of allergic reactions, including hay fever, hives, and allergic conjunctivitis. It works by blocking H1 receptors to reduce the effects of histamine in the body.
Detailed information about Dexchlorpheniramine
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Dexchlorpheniramine.
Dexchlorpheniramine is a potent first-generation antihistamine (a medication used to treat allergy symptoms) that belongs to the alkylamine chemical class. Specifically, it is the dextrorotatory isomer (the right-handed molecular version) of chlorpheniramine. According to the FDA-approved labeling history, this medication has been utilized for decades to manage various allergic conditions due to its high affinity for H1 receptors. As a first-generation agent, dexchlorpheniramine is known for its ability to cross the blood-brain barrier (the protective membrane surrounding the brain), which contributes to both its therapeutic effects and its common side effect of sedation (drowsiness).
Healthcare providers typically prescribe dexchlorpheniramine maleate to alleviate symptoms associated with perennial and seasonal allergic rhinitis (hay fever), vasomotor rhinitis (non-allergic nasal congestion), and allergic conjunctivitis (eye allergies). It is also frequently used to treat uncomplicated skin manifestations of urticaria (hives) and angioedema (swelling under the skin). In clinical settings, it may be used as an adjunct to epinephrine for the management of anaphylactic reactions (severe, life-threatening allergic reactions) after the acute manifestations have been controlled.
To understand how dexchlorpheniramine works, it is essential to understand the role of histamine in the human body. Histamine is a naturally occurring chemical released by mast cells (immune cells) during an allergic reaction. When histamine binds to H1 receptors located on blood vessels, smooth muscles, and sensory nerves, it causes the classic symptoms of allergies: itching, swelling, mucus production, and redness.
Dexchlorpheniramine acts as a competitive H1-receptor antagonist (a substance that blocks a receptor). On a molecular level, it competes with free histamine for binding sites on the effector cells (the cells that respond to histamine). By occupying these receptor sites, dexchlorpheniramine prevents histamine from initiating the inflammatory cascade. Unlike second-generation antihistamines (such as loratadine or cetirizine), dexchlorpheniramine is highly lipophilic (fat-soluble), allowing it to penetrate the central nervous system (CNS). While this leads to its sedative properties, it also makes it effective for certain types of nausea or allergic reactions that involve the CNS.
The way the body processes dexchlorpheniramine is critical for determining its dosing schedule and potential for interactions.
Dexchlorpheniramine is FDA-approved for the symptomatic treatment of several conditions. These include:
In some cases, healthcare providers may use dexchlorpheniramine off-label (a use not specifically approved by the FDA) for the short-term management of insomnia related to allergy symptoms or for the prevention of motion sickness, although other medications are often preferred for these purposes.
Dexchlorpheniramine maleate is available in several formulations to accommodate different patient needs:
> Important: Only your healthcare provider can determine if Dexchlorpheniramine is right for your specific condition. The choice of formulation and dosage will depend on your age, the severity of your symptoms, and your overall medical history.
For the treatment of allergic conditions, the standard adult dosage of dexchlorpheniramine maleate is typically as follows:
Pediatric dosing must be calculated with extreme care to avoid toxicity. According to the American Academy of Pediatrics and FDA guidelines, first-generation antihistamines should be used with caution in young children.
Because dexchlorpheniramine is primarily excreted by the kidneys, patients with significant kidney disease (renal impairment) may require lower doses or extended dosing intervals. Accumulation of the drug can lead to increased side effects, particularly sedation and anticholinergic effects (dry mouth, urinary retention).
Since the liver is the primary site of metabolism for this drug, patients with liver disease (hepatic impairment) should be monitored closely. Reduced liver function can slow the breakdown of the medication, leading to higher levels in the bloodstream.
Patients aged 65 and older are more sensitive to the effects of dexchlorpheniramine. The 2023 Beers Criteria from the American Geriatrics Society recommends avoiding first-generation antihistamines in the elderly due to the high risk of falls, confusion, and urinary retention. If use is necessary, healthcare providers typically start with the lowest possible dose.
To ensure the best results and minimize side effects, follow these guidelines:
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up, as this increases the risk of toxicity.
An overdose of dexchlorpheniramine can be life-threatening. Symptoms may include extreme drowsiness, dilated pupils, fever, flushing, hallucinations, tremors, and seizures. In children, an overdose may cause paradoxical excitation (restlessness and agitation) followed by a coma. If an overdose is suspected, contact your local poison control center or seek emergency medical attention immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Misuse of antihistamines can lead to serious health complications.
The most frequently reported side effect of dexchlorpheniramine is somnolence (drowsiness). Because this medication crosses the blood-brain barrier, it has a significant sedative effect. Patients often describe feeling "groggy" or "tired." This effect is most pronounced during the first few days of treatment and may diminish as the body adjusts to the medication. Other common effects include:
These side effects occur in a smaller percentage of the population but are still well-documented:
Rarely, patients may experience more unusual reactions, such as:
> Warning: Stop taking Dexchlorpheniramine and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of first-generation antihistamines like dexchlorpheniramine has been associated with certain risks in clinical studies. Chronic use may lead to tolerance, where the medication becomes less effective over time, requiring higher doses to achieve the same relief. There is also emerging research suggesting that long-term use of drugs with high anticholinergic activity may be linked to an increased risk of cognitive decline or dementia in older adults, although more research is needed to confirm this specific link for dexchlorpheniramine.
Currently, there are no FDA black box warnings specifically for dexchlorpheniramine maleate. However, it carries significant class-wide warnings regarding its use in newborns and premature infants due to the risk of severe respiratory depression and death. It is also contraindicated in patients currently taking Monoamine Oxidase Inhibitors (MAOIs).
Report any unusual symptoms to your healthcare provider. Monitoring your body's response to the medication is a vital part of safe treatment.
Dexchlorpheniramine is a potent medication that requires careful management. The most critical safety point for patients is the risk of Central Nervous System (CNS) depression. Because the drug causes significant drowsiness, it can impair your ability to perform tasks that require mental alertness. Patients should be cautioned against engaging in hazardous activities until they are certain how the medication affects them. Furthermore, the sedative effects of dexchlorpheniramine are cumulative when combined with other substances that depress the CNS, such as alcohol or certain pain medications.
No FDA black box warnings for Dexchlorpheniramine. However, healthcare providers strictly adhere to the contraindication against use in neonates and nursing mothers, as infants are particularly susceptible to the toxic effects of antihistamines.
For short-term use, extensive lab monitoring is typically not required. However, for patients on long-term therapy, healthcare providers may occasionally order:
Dexchlorpheniramine significantly impairs motor skills and reaction times. You should not drive a car, operate heavy machinery, or participate in any activity that requires full concentration until you are sure that the medication does not make you drowsy or dizzy. Many accidents involving antihistamines occur because patients underestimate the level of impairment they are experiencing.
Alcohol must be avoided while taking dexchlorpheniramine. Alcohol acts as a potent synergist with first-generation antihistamines, meaning it multiplies the sedative effects. This combination can lead to dangerous levels of respiratory depression, extreme lethargy, and an increased risk of accidents or falls.
For most patients, dexchlorpheniramine can be stopped without a tapering schedule. However, if you have been taking it daily for a long period, you may experience "rebound" symptoms, such as increased nasal congestion or itching, once the drug is stopped. Always consult your doctor before ending a long-term treatment plan.
> Important: Discuss all your medical conditions with your healthcare provider before starting Dexchlorpheniramine. A full review of your health history is necessary to prevent dangerous complications.
There are certain medications that should never be combined with dexchlorpheniramine due to the risk of life-threatening interactions:
Dexchlorpheniramine can interfere with the results of allergy skin tests. Because the medication prevents the skin from reacting to allergens, it can produce false-negative results. You should typically stop taking all antihistamines at least 48 to 72 hours before undergoing allergy skin testing. Always inform the technician or doctor that you have been taking this medication.
For each major interaction, the mechanism usually involves either pharmacodynamic synergism (where two drugs have the same effect, leading to an overdose-like state) or pharmacokinetic interference (where one drug changes how the other is absorbed or metabolized). The clinical consequence is usually increased toxicity (too much effect) or, less commonly, reduced efficacy.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is the only way to ensure your safety.
Absolute contraindications are conditions or factors that serve as a reason to withhold a certain medical treatment due to the harm that it would cause the patient. For dexchlorpheniramine, these include:
Relative contraindications require a careful risk-benefit analysis by a healthcare provider. These include:
Patients who are allergic to chlorpheniramine (Chlor-Trimeton) are almost certain to be allergic to dexchlorpheniramine, as they are chemically nearly identical. There may also be cross-sensitivity with other alkylamine antihistamines such as triprolidine or brompheniramine. If you have had a reaction to any antihistamine in the past, it is vital to inform your healthcare provider before starting dexchlorpheniramine.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Dexchlorpheniramine. Never share your medication with others, even if they have similar symptoms.
Dexchlorpheniramine is generally classified as FDA Pregnancy Category B. This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. While many healthcare providers consider dexchlorpheniramine one of the safer antihistamines for use during pregnancy, it should only be used if clearly needed. Use during the third trimester is particularly sensitive, as newborns may experience withdrawal symptoms or be more sensitive to the drug's effects if it is in their system at the time of birth. Always consult an obstetrician before using any antihistamine during pregnancy.
Dexchlorpheniramine is contraindicated in nursing mothers. Small amounts of the drug pass into breast milk. Because of the higher risk of antihistamines causing irritability, disturbed sleep patterns, or even seizures in infants—and because these drugs may inhibit lactation (reduce milk supply) by lowering prolactin levels—breastfeeding women should avoid this medication. If allergy treatment is necessary, healthcare providers usually recommend second-generation antihistamines that have better safety profiles for nursing.
Dexchlorpheniramine is approved for use in children as young as 2 years old, but with strict dosing requirements. It is not approved for use in children under 2 years of age. In pediatric patients, the risk of "paradoxical excitation" is much higher than in adults; children may become hyperactive, agitated, or experience hallucinations rather than becoming sleepy. Parents must be warned not to use this medication to make a child sleepy or as a sleep aid.
In patients over 65, the use of dexchlorpheniramine is generally discouraged. According to the Beers Criteria (2023), the risks often outweigh the benefits for this population. Older adults have a reduced clearance of the drug, meaning it stays in their system longer. This increases the risk of:
Patients with a glomerular filtration rate (GFR) below 50 mL/min should use dexchlorpheniramine with caution. While specific dose-adjustment tables are not always provided in the labeling, a common clinical practice is to increase the interval between doses (e.g., every 8-12 hours instead of every 4-6 hours) to prevent drug accumulation.
For patients with mild to moderate hepatic impairment (Child-Pugh Class A or B), the half-life of the drug may be significantly extended. Healthcare providers typically start these patients on the lowest possible dose and monitor for signs of excessive sedation or anticholinergic toxicity.
> Important: Special populations require individualized medical assessment. Age, organ function, and pregnancy status significantly change how this drug behaves in the body.
Dexchlorpheniramine maleate is a highly selective H1-receptor antagonist. It works through competitive inhibition; it competes with histamine for the H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. By binding to these receptors, it prevents the physiological actions of histamine, which include vasodilation (widening of blood vessels), increased capillary permeability (leading to swelling), and the stimulation of sensory nerves (causing itching).
Additionally, dexchlorpheniramine possesses significant anticholinergic (antimuscarinic) activity. It blocks acetylcholine from binding to its receptors, which leads to the "drying" effects of the medication—reducing nasal secretions but also causing side effects like dry mouth and urinary retention. Unlike newer antihistamines, its ability to cross the blood-brain barrier allows it to bind to H1 receptors in the brain, which is the primary cause of its sedative effect.
The onset of action for dexchlorpheniramine is relatively rapid, with symptomatic relief typically beginning within 30 to 60 minutes after oral administration. The peak effect occurs around 2 to 4 hours. The duration of action for immediate-release forms is generally 4 to 8 hours, while timed-release formulations can provide relief for up to 12 hours. Tolerance to the sedative effects may develop after several days of continuous use, but the anti-allergy effects usually remain consistent.
| Parameter | Value |
|---|---|
| Bioavailability | Approximately 70% |
| Protein Binding | 70% - 75% |
| Half-life | 20 - 30 hours (Adults) |
| Tmax (Time to peak) | 2 - 6 hours |
| Metabolism | Hepatic (N-dealkylation) |
| Excretion | Renal (primarily as metabolites) |
Dexchlorpheniramine is classified as a First-Generation Antihistamine and an Alkylamine derivative. Within the broader therapeutic area of allergy medications, it is grouped with other older agents like diphenhydramine (Benadryl) and chlorpheniramine (Chlor-Trimeton). While newer second-generation antihistamines (like fexofenadine) are often preferred for daily use due to their lack of sedation, first-generation agents like dexchlorpheniramine remain highly effective for acute allergic reactions and situations where a stronger antihistamine effect is required.
Medications containing this ingredient
Common questions about Dexchlorpheniramine
Dexchlorpheniramine is primarily used to treat symptoms of allergic reactions, such as sneezing, runny nose, itching, and watery eyes associated with hay fever or other upper respiratory allergies. It is also highly effective for treating skin conditions like hives (urticaria) and the swelling associated with angioedema. Healthcare providers may also use it to manage allergic reactions to blood transfusions or as an add-on treatment for severe anaphylactic reactions. Because it is a first-generation antihistamine, it is often chosen when a potent effect is needed for acute symptoms. It is available in various forms, including immediate-release tablets, timed-release tablets, and syrups.
The most common side effect of dexchlorpheniramine is significant drowsiness or sedation, which affects a large majority of users. Many people also experience anticholinergic effects, such as a very dry mouth, nose, or throat. Blurred vision and urinary hesitancy (difficulty starting to pee) are also frequently reported. Some patients may feel dizzy or experience a 'heavy' feeling in their limbs. Gastrointestinal issues, like nausea or constipation, can also occur, though these are often minimized by taking the medication with food.
No, you should strictly avoid alcohol while taking dexchlorpheniramine. Both alcohol and dexchlorpheniramine are central nervous system depressants, and when taken together, they can dangerously increase each other's effects. This combination can lead to extreme drowsiness, severely impaired motor skills, and an increased risk of respiratory depression. It also significantly raises the risk of accidents, falls, and injuries. Even small amounts of alcohol can interact poorly with this medication, so it is best to abstain entirely during treatment.
Dexchlorpheniramine is classified as FDA Pregnancy Category B, meaning it is generally considered one of the safer antihistamines for use during pregnancy, but it should still only be used when clearly necessary. There are no definitive studies in humans that prove it is 100% safe for all pregnant women. Most doctors recommend avoiding its use during the third trimester to prevent potential side effects in the newborn. You should always discuss the risks and benefits with your obstetrician before starting this medication. If you are pregnant, your doctor may suggest alternative treatments or a specific dosage tailored to your needs.
Dexchlorpheniramine typically begins to work quite quickly, with most patients noticing a reduction in allergy symptoms within 30 to 60 minutes of taking an oral dose. The medication reaches its peak concentration in the bloodstream between 2 and 6 hours after ingestion. For the immediate-release versions, the effects usually last for about 4 to 8 hours. If you are taking the timed-release (sustained-release) tablets, the onset may be similar, but the medication will continue to work for up to 12 hours. If your symptoms do not improve after a few days of use, you should contact your healthcare provider.
Yes, for most people, dexchlorpheniramine can be stopped suddenly without causing dangerous withdrawal symptoms. Unlike some other classes of medication, it does not typically require a tapering period. However, if you have been using it daily for a long time, you might experience a 'rebound' effect where your allergy symptoms, like itching or congestion, temporarily become worse than they were before. If you have been using it for an extended period, it is always a good idea to check with your doctor before stopping. They can help you transition to a different allergy management strategy if needed.
If you miss a dose of dexchlorpheniramine, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and simply take the next one at the regular time. Never take two doses at once to make up for a missed one, as this significantly increases your risk of experiencing side effects like extreme drowsiness or dry mouth. Maintaining a consistent schedule helps keep the medication at an effective level in your body. If you frequently forget your doses, using a pill organizer or a phone reminder can be very helpful.
Weight gain is not a commonly reported side effect of dexchlorpheniramine, especially when used for short-term allergy relief. However, some first-generation antihistamines can increase appetite in some individuals, which might lead to weight gain over long-term use. Additionally, the sedation caused by the drug might lead to decreased physical activity, which could indirectly contribute to weight changes. If you notice an unusual increase in weight while taking this medication, you should discuss it with your doctor. They can help determine if the medication is the cause or if there is another underlying factor.
Dexchlorpheniramine can interact with many other drugs, so it is vital to consult your doctor or pharmacist before combining it with other treatments. It should never be taken with Monoamine Oxidase Inhibitors (MAOIs) or other strong sedatives. It can also have additive effects if taken with other medications that cause dry mouth or constipation, such as certain antidepressants or bladder control drugs. Even over-the-counter cold or sleep medicines may contain ingredients that interact with dexchlorpheniramine. Always provide your healthcare provider with a full list of all prescriptions, supplements, and herbal products you are currently using.
Yes, dexchlorpheniramine maleate is available as a generic medication in several forms, including tablets and oral solutions. Generic versions are typically more cost-effective than brand-name products while providing the same clinical benefits and safety profile. In the United States, it was originally marketed under the brand name Polaramine, though that brand is less common now than generic alternatives. When purchasing the medication, check the active ingredients label to ensure it contains dexchlorpheniramine maleate. Your pharmacist can help you identify the most affordable generic option available at your local pharmacy.